Inhibition of thyroid cathepsin D activity by pepstatin.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002403:Cathepsins / Q000037:antagonists & inhibitors*; D002746:Chlorpromazine / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis; D005966:Glucuronidase / Q000096:biosynthesis; D066298:In Vitro Techniques; D009842:Oligopeptides / Q000494:pharmacology*; D010436:Pepstatins / Q000494:pharmacology*; D051381:Rats; D013961:Thyroid Gland / Q000378:metabolism*; D013972:Thyrotropin / Q000494:pharmacology
D009842:Oligopeptides; D010436:Pepstatins; D003994:Bucladesine; D013972:Thyrotropin; D000242:Cyclic AMP; D005966:Glucuronidase; D002403:Cathepsins; D015056:1-Methyl-3-isobutylxanthine; D002746:Chlorpromazine